Vascular density in human melanoma xenografts: Relationship to angiogenesis, perfusion and necrosis

Cancer Letters

Volumn 123, Issue 2, 1998, Pages 159-165

  Tufto, Ingunn ^a   Lyng, Heidi ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiogenesis; Melanoma xenografts; Necrosis; Perfusion rate; Vascular density

Indexed keywords

RUBIDIUM 86;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOMETRY; TISSUE PERFUSION; TUMOR NECROSIS; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NECROSIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; REGIONAL BLOOD FLOW; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032579448     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00424-2     Document Type: Article

References (25)

1. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 43:1985;175-203.
2. Shubik P. Vascularization of tumors: a review. J. Cancer Res. Clin. Oncol. 103:1982;211-226.
3. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 49:1989;6449-6465.
4. Less J.R., Skalak T.C., Sevick E.M., Jain R.K. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res. 51:1991;265-273.
5. Jain R.K. Determinants of tumor blood flow: a review. Cancer Res. 48:1988;2641-2658.
6. Steinberg F., Konerding M.A., Streffer C. The vascular architecture of human xenotransplanted tumors: histological, morphometrical, and ultrastructural studies. J. Cancer Res. Clin. Oncol. 116:1990;517-524.
7. Chaplin D.J., Olive P.L., Durand R.E. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res. 47:1987;597-601.
8. Chaplin D.J., Hill S.A. Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. Br. J. Cancer. 71:1995;1210-1213.
9. Solesvik O.V., Rofstad E.K., Brustad T. Vascular structure of five human malignant melanomas grown in athymic nude mice. Br. J. Cancer. 46:1982;557-567.
10. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:1995;9-19.
11. Siracká E., Siracký J., Pappová N., Révész L. Vascularization and radiocurability in cancer of the uterine cervix. A retrospective study. Neoplasma. 29:1982;183-188.
12. Siracká E., Révész L., Kovác R., Siracký J. Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy. Int. J. Cancer. 41:1988;819-822.
13. Degner F.L., Sutherland R.M. Mathematical modelling of oxygen supply and oxygenation in tumor tissues: prognostic, therapeutic, and experimental implications. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;391-397.
14. Groebe K., Vaupel P. Evaluation of oxygen diffusion distances in human breast cancer xenografts using tumor-specific in vivo data: role of various mechanisms in the development of tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;691-697.
15. Rofstad E.K. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer. 70:1994;804-812.
16. E.R. Weibel, Stereological Methods, Academic Press, London, 1979.
17. Kreisle R.A., Ershler W.B. Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. J. Natl. Cancer Inst. 80:1988;849-854.
18. Runkel S., Hunter N., Milas L. An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice. Radiat. Res. 126:1991;237-243.
19. Sapirstein L.A. Regional blood flow by fractional distribution of indicators. Am. J. Physiol. 193:1958;161-168.
20. Lyng H., Skretting A., Rofstad E.K. Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res. 52:1992;584-592.
21. T. Danielsen, E.K. Rofstad, VEGF, bFGF, and EGF in the angiogenesis of human melanoma xenografts, Int. J. Cancer (1997), submitted.
22. Pötgens A.J.G., Lubsen N.H., van Altena M.C., Schoenmakers J.G.G., Ruiter D.J., de Waal R.M.W. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am. J. Pathol. 146:1995;197-209.
23. Pötgens A.J.G., van Altena M.C., Lubsen N.H., Ruiter D.J., de Waal R.M.W. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am. J. Pathol. 148:1996;1203-1217.
24. Claffey K.P., Brown L.F., del Aguila L.F., Tognazzi K., Yeo K.T., Manseau E.J., Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56:1996;172-181.
25. Steinberg F., Konerding M.A., Sander A., Streffer C. Vascularization, proliferation and necrosis in untreated human primary tumors and untreated human xenografts. Int. J. Radiat. Biol. 60:1991;161-168.